幹細胞アッセイの世界市場予測(~2021年)...市場調査レポートについてご紹介

【英文タイトル】Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Lucrative Opportunities in the Global Stem Cells Market
4.2 Regional Analysis: Stem Cell Assay Market, By Kits, 2016

5 Market Overview (Page No. – 30)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Stem Cell Assay Market Segmentation, Assay Types
5.2.2 Stem Cell Assay Market Segmentation, By Kits
5.2.3 Stem Cell Assay Market Segmentation, By Application
5.2.4 Stem Cell Assay Market Segmentation, By End User
5.2.5 Stem Cell Assay Market Segmentation, By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Investment in Research Related Activities
5.3.1.2 Technological Advancements
5.3.1.3 Funding for Stem Cell Research
5.3.2 Restraints
5.3.2.1 Affordability of Stem Cell Therapies & Treatments
5.3.2.2 Slow Response Time of Regulatory Bodies & Training Needs
5.3.3 Opportunities
5.3.3.1 Evolving Market & Fast Changing Market Dynamics
5.3.4 Challenges
5.3.4.1 Unapproved Stem Cell Operations

6 Stem Cell Assay Market, By Technology (Page No. – 38)
6.1 Introduction
6.1.1 Technology Roadmap
6.1.2 Figure 1.1 Stem Cell Assay Market, By Technology
6.1.3 Micro Fabricated Assisted Technology
6.1.3.1 Microfluidics Based Cell Trap Technologies
6.1.4 Technology in Development

7 Stem Cell Assay Market, By Assay (Page No. – 44)
7.1 Introduction
7.1.1 Cell Viability & Toxicity Assays
7.1.2 Isolation/Purification Assays
7.1.3 Cell Identification Assays
7.1.4 Cell Proliferation Assays
7.1.5 Cell Differentiation Assays
7.1.6 Cell Function Assays
7.1.7 Cell Apoptosis Assays

8 Stem Cell Assay Market, By Kits (Page No. – 56)
8.1 Introduction
8.2 Adult Stem Cell Kits
8.2.1 Mesenchymal Stem Cell Kits
8.2.2 Induced Pluripotent Stem Cell Kits
8.2.3 Hematopoietic Stem Cell Kits
8.2.4 Neuronal Stem Cells Kits
8.2.5 Umbilical Cord Stem Cells
8.3 Human Embryonic Stem Cells Kits

9 Stem Cell Assay Market, By Product (Page No. – 69)
9.1 Introduction
9.2 Figure 1.1 Stem Cell Assay Market, By Product
9.3 Instruments
9.3.1 Micro Electrode Arrays
9.3.2 Flow Cytometer
9.3.3 Cell Imaging Systems
9.3.4 Automated Cell Counter
9.4 Detection Kits
9.4.1 Immuno Histochemistry Kits

10 Stem Cell Assays Market, By Application (Page No. – 80)
10.1 Introduction
10.2 Regenerative Medicine & Therapy Development
10.2.1 Orthopedic & Musculoskeletal Spine
10.2.2 Dermatology
10.2.3 Cardiovascular
10.2.4 Central Nervous System
10.2.5 Oncology
10.2.6 Diabetes
10.2.7 Others
10.3 Drug Discovery and Development
10.4 Clinical Research

11 Stem Cell Assays, By End User (Page No. – 97)
11.1 Introduction
11.2 Research Institutes
11.3 Industry Research

12 Regional Analysis (Page No. – 103)
12.1 Introduction
12.2 North America
12.3 Europe
12.4 Asia-Pacific
12.5 Rest of the World (RoW)

13 Competitive Landscape (Page No. – 146)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.3.1 Approvals
13.3.2 Agreements, Partnerships & Collaborations
13.3.3 Acquisitions
13.3.4 Expansions
13.3.5 Other Developments

14 Company Profiles (Page No. – 152)
14.1 Introduction
14.2 GE Healthcare
14.2.1 Business Overview
14.2.2 Company Snapshot GE Healthcare
14.2.3 Product Portfolio
14.2.4 Recent Developments
14.2.5 MnM View
14.3 Promega Corporation
14.3.1 Business Overview
14.3.2 Company Snapshot: Promega Corporation
14.3.3 Product Portfolio
14.3.4 Recent Developments
14.3.5 MnM View
14.4 Thermo Fisher Scientific Pvt. Ltd
14.4.1 Business Overview
14.4.2 Company Snapshot: Thermo Fisher Scientific
14.4.3 Product Portfolio
14.4.4 Recent Developments
14.4.5 MnM View
14.5 Merck Millipore
14.5.1 Business Overview
14.5.2 Company Snapshot: Merck Millipore
14.5.3 Product Portfolio
14.5.4 Recent Developments
14.5.5 MnM View
14.6 Cell Bio Labs, Inc.
14.6.1 Business Overview
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.6.4 MnM View
14.7 Hemogenix Inc.
14.7.1 Business Overview
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.7.4 MnM View
14.8 Stem Cell Technologies
14.8.1 Business Overview
14.8.2 Product Portfolio
14.8.3 Recent Developments
14.8.4 MnM View
14.9 Bio Rad
14.9.1 Business Overview
14.9.2 Company Snapshot: Bio Rad
14.9.3 Product Portfolio
14.9.4 Recent Developments
14.9.5 MnM View
14.10 R&D Systems
14.10.1 Business Overview
14.10.2 Company Snapshot: R&D Sysytems
14.10.3 Product Portfolio
14.10.4 MnM View
14.11 Cellular Dynamics International.
14.11.1 Business Overview
14.11.2 Product Portfolio
14.11.3 Recent Developments
14.11.4 MnM View

15 Appendix (Page No. – 175)
15.1 Insights From Industry Experts
15.2 Discussion Guide
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports


【レポート販売概要】

■ タイトル:幹細胞アッセイの世界市場予測(~2021年)
■ 英文:Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021
■ 発行日:2016年10月7日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-4628
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。